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Abstract 
Background: Mesenchymal stromal cells cultivated from the corneal limbus (L-MSC) 
provide a potential source of cells for corneal repair. We presently investigate the 
immunosuppressive properties of human L-MSC and putative rabbit L-MSC, with the view 
to developing an allogeneic therapy and animal model of L-MSC transplantation 
respectively. Methods: MSC-like cultures were established from the limbal stroma of human 
and rabbit  (New Zealand White) corneas using either serum-supplemented medium or a 
commercial serum-free MSC medium (MesenCult-XF
®
 system). L-MSC phenotype was 
examined by flow cytometry. The immunosuppressive properties of L-MSC cultures were 
assessed using mixed leukocyte reactions. L-MSC cultures were also tested for their ability to 
support colony formation by primary limbal epithelial (LE) cells. Results: Human L-MSC 
cultures were typically CD34, CD45 and HLA-DR negative, and CD73, CD90, CD105 and 
HLA-ABC positive. High levels (>80%) of CD146 expression were observed for L-MSC 
cultures grown in serum-supplemented medium, but not those grown in MesenCult-XF
®
 
(~1%). Rabbit L-MSC were ~95% positive for MHC Class I, and expressed lower levels of 
MHC-II (~10%), CD45 (~20%), CD105 (~60%) and CD90 (<10%). hL-MSC and rL-MSC 
suppressed human T-cell proliferation by up to 75%. Conversely L-MSC from either species 
stimulated a two to three-fold increase in LE colony formation. Discussion: L-MSC display 
immunosuppressive qualities in addition to their established non-immunogenic profile, and 
stimulate LE cell growth in vitro across species boundaries. These results support the 
potential use of allogeneic L-MSC in the treatment of corneal disorders and suggest that the 
rabbit will provide a useful pre-clinical model. 
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Abbreviations 
APC - Allophycocyanin 
α-sma – Alpha smooth muscle actin 
BM-MSC – Bone marrow mesenchymal stromal cells 
CD – Cluster of differentiation 
DMEM – Dulbecco’s Modified Eagle’s Medium 
EGF – Epidermal growth factor 
FBS – Foetal bovine serum 
FGF-2 – Fibroblast growth factor 2 
FITC – Fluorescein isothiocyanate 
HLA – Human leukocyte antigen 
hLE – Human limbal epithelial 
hL-MSC – Human limbal mesenchymal stromal cells 
LE – Limbal epithelium 
L-MSC – Limbal mesenchymal stromal cells 
LSCD – Limbal stem cell deficiency 
MLR – Mixed leukocyte reaction 
MSC – Mesenchymal stromal cell 
NGS – Normal goat serum 
NZW – New Zealand White (rabbit) 
PBMC – Peripheral blood mononuclear cell 
PBS – Phosphate buffered saline 
PE – Phycoerythrin 
rLE – rabbit limbal epithelium 
rL-MSC – rabbit limbal mesenchymal stromal cells 
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Introduction 
The corneal limbus is a narrow transitional zone of tissue located between the cornea and 
surrounding scleral tissue. Epithelial progenitor cells for replenishing the human corneal 
epithelium are concentrated within the basal layer of the limbal epithelium (1). This 
knowledge has been exploited to provide an effective cellular therapy for reconstructing the 
ocular surface (2-4). More recently, attention has turned to studying the progenitor cell 
potential of cells cultivated from the limbal stroma (5-12). One useful model for studying the 
biology of these putative limbal stromal progenitors has been to draw comparisons with 
mesenchymal stromal cells (MSC) found in cultures established from other tissues such as 
bone marrow (BM-MSC). 
 Polisetty and colleagues (11) first proposed the concept of a limbal mesenchymal 
stem/stromal cell (L-MSC) after discovering that cultures established from the human limbal 
stroma displayed a similar profile of cell surface antigens to BM-MSC. Subsequent studies 
by this same group led to the conclusion that L-MSC might contribute to maintenance of the 
limbal epithelial stem cell niche (10). Data arising from other studies (6, 12, 13) supports the 
“niche stromal cell” hypothesis by demonstrating that cultures established from limbal stroma 
provide an effective feeder layer for the ex vivo expansion of limbal epithelial cells. The 
limbal stroma has also been proposed as a source of progenitor cells for repairing the corneal 
stroma (8). 
 An important consideration for therapies based upon the use of L-MSC is to 
determine a suitable source of these cells. Under ideal conditions, cultures of L-MSC might 
be sourced from a patient’s own healthy tissue. While the experience of growing limbal 
epithelium from patient biopsies demonstrates that the required amount of tissue can be 
safely removed from healthy patient eyes (14), allogeneic donor tissue would offer significant 
advantages as a source of pre-expanded and banked L-MSC that could be used for the 
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treatment of patients afflicted with conditions affecting either one or both eyes. This 
treatment model would be dependent, however, on the donor L-MSC displaying low-
immunogenicity. To this end, while donor limbal tissue transplants display a high rate of 
immunological rejection (15), L-MSC cultured in standard serum-supplemented growth 
medium, like BM-MSC, display a low immunogenic profile by virtue of low levels of HLA-
DR expression (5, 7, 11). Recent studies by our own group, however, suggest that optimal 
growth of L-MSC is achieved using the MesenCult-XF culture system (6) and HLA-DR 
expression under these conditions remains unknown. More recently, Garfias et al (7) have 
reported that soluble factors secreted by L-MSC suppress T-cell proliferation by up to 30%. 
Presumably, this immunosuppressive property might also be observed when donor L-MSCs 
are placed in direct contact with a patient’s immune cells, but this study has yet to be 
performed.  
We presently extend the field of L-MSC research in three critical ways. To begin, we 
build upon our earlier studies of the effect of culture conditions on L-MSC phenotype (6) by 
examining the expression of human leukocyte antigens (HLA) when these cells are grown in 
either standard serum-supplemented growth medium or using the MesenCult-XF system. 
Secondly, we explore in vitro the potential existence of a cell with equivalent “stem cell 
niche properties” to human L-MSC, in cultures established from the limbal stroma of New 
Zealand White (NZW) rabbits, the established pre-clinical model for cultured limbal 
epithelial cell transplants (4, 16-20). Thirdly, we have explored the immunosuppressive 
properties of both human L-MSC, as well as their putative rabbit cell equivalents, when 
cultured in direct contact with immune cells isolated from two mis-matched human donors. 
In doing so, we seek to establish the feasibility of allogeneic L-MSC therapies and to propose 
the NZW rabbit as a potential pre-clinical model of L-MSC transplantation. 
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Materials and methods 
 
Establishment of cultures from human and rabbit limbal stroma 
Human corneal tissue was obtained with ethics approval and donor consent from the 
Queensland Eye Bank (QEB), Brisbane, Australia. Whole rabbit eyes (adult New Zealand 
White) were retrieved from euthanased animals via a tissue sharing agreement with the 
Medical Engineering Research Facility at the Queensland University of Technology. Prior to 
digestion, tissue was dissected down to a 1.5 - 2 mm diameter across the limbal transition 
between transparent cornea and white sclera. The tissue was washed in three changes of 
phosphate buffered saline (PBS; Life Technologies, Melbourne, Australia) then digested with 
0.25% dispase (Life Technologies) for 1 h at 37 ºC to assist removal of limbal epithelial (LE) 
cells. The LE were cultured for subsequent use in colony formation assays with stromal cells 
(see below). The remaining limbal stroma was digested in 1 mg/ml Collagenase Type I for 48 
h in DMEM/F12 (both Life Technologies). The dissociated stromal cells were washed and 
initially seeded at a density of 5 × 10
3
 cells/mL where possible under culture conditions as 
described previously (6). The culture medium for both species consisted of DMEM/F12 
medium supplemented with GlutaMax (Life Technologies) and 10% foetal bovine serum 
(FBS; Hyclone Thermo Scientific, Melbourne, Australia). For simplicity this first medium is 
subsequently referred to as 10% FBS medium, and for hL-MSC was compared to the 
MesenCult®-XF culture system (Stem Cell Technologies, Melbourne, Australia), a serum-
free culture system designed for cultivation of human-derived MSC. Both media were 
additionally supplemented with 1% penicillin/streptomycin solution (Life Technologies).   
 
Flow cytometry 
7 
For analysis of hL-MSC we used; mouse IgG1 к isotype control phycoerythrin (PE) (MOPC-
21), mouse IgG2b к isotype control PE (27-35), rat IgG2a к isotype control PE (R35-95), and 
the following mouse or rat anti-human antibodies: CD29 (FITC, TS2/16, IgG1 к), CD34 
(FITC, 581/CD34, IgG1 к), CD44 (Pacific Blue, 581/CD34, IgG1 к), CD45 (PE-cyanine dye 
Cy7, HI30, IgG1 к), CD73 (APC, AD2, IgG1 к), CD90 (APC, 5E10, IgG1 к), CD105 (PE, 
SN6, IgG1 к), CD141 (PE, 1A4, IgG1 к), CD146 (FITC, P1H12, IgG1 к), HLA-ABC 
(purified, G46-2.6, IgG1 к), and HLA-DR (purified, 46-6, IgG2a к). For analysis of rabbit L-
MSC we used anti-rabbit antibodies to CD45 (purified L12/201, IgG1), CD90 (Alexa Fluor 
647, OX-7, IgG1), MHC Class I Tissue Culture Supernatant (73.2, IgG1) and MHC Class II 
(purified, 2C4, IgG2a). Owing to the scarcity of antibodies raised against rabbit antigens we 
supplemented this panel with those used to examine human L-MSC and also tested the 
following rat anti-mouse or hamster anti-mouse antibodies to CD29 (APC, HMb1-1, IgG), 
CD44 (FITC, IM7, IgG2b к), CD45 (APC, 30-F11, IgG2b к) and CD90.2 (PE, 53-2.1, IgG2b 
к). All antibodies were purchased from Becton-Dickinson (BD Pharmingen, San Jose, USA), 
Ebioscience (in the case of CD29, CD73, CD105, and CD146; Jomar Bioscience, Adelaide, 
Australia), or AbD Serotec (in the case of MHC Class I, MHC Class II, mouse anti-rabbit 
CD45, and mouse anti-rat CD90; Abacus ALS, Brisbane, Australia). Purified primary 
antibodies were detected using a goat anti-mouse Alexa Fluor 488 conjugated secondary 
antibody (Life Technologies). Cell viability was assessed by 7-amino-actinomycin D 
incorporation (BD Viaprobe cell viability solution). Antibody concentrations were used 
according to manufacturers’ instructions. Fifty thousand events were collected for each test 
on a BD LSRII (BD Biosciences, San Jose, USA) and analysed using FlowJo version 10 
software (Tree Star Inc., Ashland, USA).  
 
Immunostaining 
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Immunocytochemistry was performed to determine the expression of α-smooth muscle actin 
in cultured rL-MSC. Briefly, cultures were fixed in 10% neutral buffered formalin, washed in 
PBS, then blocked and permeabilised in 0.1% Triton X-100 with 5% normal goat serum 
(NGS) in PBS for 1 h at 37 ºC. Cultures were then incubated for 1 hr at 37 ºC in 1% 
NGS/PBS containing a 1:100 dilution of primary antibody to human α-sma (Dako Australia 
Pty Ltd, Melbourne, Australia). After washing three times in PBS an Alexa Fluor 488 goat 
anti-mouse IgG secondary antibody (Life Technologies) was applied for 1 h at 37 ºC. Total 
cell numbers was revealed by counterstaining with Hoechst nuclear stain in Hepes buffered 
saline for 15 minutes. 
 
Mixed leukocyte reactions 
The immunosuppressive properties of L-MSC were measured using allogeneic two-way 
mixed-donor leukocyte reaction (MLR) assays. This experiment utilised hL-MSC (cultivated 
in either 10% FBS media or MesenCult-XF culture system) and rL-MSC (cultivated in 10% 
FBS medium). L-MSC were seeded at 2.5 × 10
4
 cells per well, incubated for 2 days, and then 
irradiated (3000 cGy) prior to co-culture with peripheral blood mononuclear cells (PBMC). A 
1:1 mix of PBMC from two different healthy consented donors was then added (10
5
 cells 
from each donor in 10% FBS medium) to the irradiated L-MSC in each well and cultured in a 
humidified 37°C, 5% CO2 incubator. [
3
H]-thymidine was added (1 μCurie/well) (Amersham 
Biosciences, Buckinghamshire, UK) after 96 h of co-culture and T cell proliferation was 
assessed after a further 12 h incubation. Cells were harvested using the TOMTEC 96-well 
Mach III Harvester (Perkin- Elmer, Melbourne, Australia) and [
3
H]-thymidine incorporation 
measured as counts per minute (cpm) on a 1450 MICROBETA TRILUX β-scintillation 
counter (Perkin-Elmer). 
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Establishment of LE cell cultures 
Primary cultures of human and rabbit LE cells were initially established from fresh tissue and 
stored in liquid nitrogen until required for analysis. To establish cultures, rLE or hLE were 
harvested by dispase-treatment (as described earlier) before suspension of epithelial cell 
growth medium (6). This medium consisted of a 1:3 mixture of DMEM/F12 medium, 
supplemented with 10% FBS, 1% penicillin/streptomycin solution, 10 ng/mL epidermal 
growth factor, 1% v/v non-essential amino acids, 2 mM L-glutamine (all Life Technologies), 
6.8 mg 3,3,5-triiodo-L-thyronine sodium salt, 180 µM adenine, 5 µg/mL transferrin, 0.4 
µg/mL hydrocortisone, 1 µg/mL insulin (all Sigma-Aldrich, St Louis, USA), and 10
-5
 M 
isoproterenol (Calbiochem, Merck, Melbourne, Australia). During initial expansion the LE 
cells were supported by a growth arrested feeder layer of murine 3T3 fibroblasts (ATCC; 
CCL-92). Prior to use, the 3T3 cells were maintained in DMEM supplemented with 10% 
FBS and 2 mM L-glutamine prior to use. LE cell cultures were established by seeding freshly 
isolated cells into 25 cm
2
 flasks at a density of 5 × 10
5
 cells in the presence of 1 × 10
6
 3T3 
fibroblast feeder cells. Feeder cells were growth-arrested prior to seeding by gamma 
irradiation (2 x 25 gray). LE cultures were grown to approximately 80-90% confluency, 
before being stored in liquid nitrogen. All cultures were used below passage 3. 
 
LE colony formation assay 
Four different cell types were used in these experiments; hLE cells, rLE cells, hL-MSC 
established in serum-supplemented growth medium, and rL-MSC established in the serum 
supplemented growth medium. Both L-MSC cell types were freshly harvested from low 
passage number cultures (<p3) and gamma-irradiated (4 x 25 Gy) prior to seeding into 24-
well culture plates at a density of 20,000 cells/cm
2
 in epithelial growth medium described 
above. Frozen vials of LE cells for each species were then thawed, washed in epithelial 
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culture medium and seeded at a density of 5,000 cells/cm
2
 into the same 24-well plate above, 
in the absence and presence of each L-MSC cell type. After three days, the cultures were 
examined by phase contrast microscopy and the number of epithelial colonies counted per 
10x field. 
 
Statistics 
Statistical significance was determined using GraphPad Prism v6.0 software. A two-way 
analysis of variance (ANOVA) was used to compare differences in LE colony formation 
(with variables being species of LE cell type and species of L-MSC cell type). A one-way 
Analysis of Variance (ANOVA) was used to determine statistical significance in the MLR 
experiments, followed by a Tukey-Kramer Multiple Comparisons Test. Differences were 
considered to be statistically significant if calculated ‘p’ values were ˂0.05.  
 
Results 
Effect of culture conditions on the expression of HLA by hL-MSC 
In previous studies we have noted subtle differences in the phenotype of hL-MSC when using 
different culture conditions (6). The choice of culture condition may therefore have a 
significant effect on the immunological properties of L-MSC. To test this theory we 
examined the expression of the human leukocyte antigens, HLA-ABC and HLA-DR, for 
cultures grown in 10% FBS medium, compared with those grown using the MesenCult-XF
®
 
system. As summarised in Table 1, >80% of cells grown under either condition were found to 
express HLA-ABC, whereas only 20-30% of cells expressed HLA-DR. A comparison of 
MSC markers displayed little difference between culture conditions for CD29, CD44, CD73, 
CD90 and CD105 cell surface expression; although a slight increase in MSC purity and 
CD141 expression was seen in the MesenCult
®
-XF cultures. In contrast, cultures grown in 
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the presence of serum displayed a remarkably higher number of CD146+ cells (80% versus 
<5%; Fig. 1A) compared with those grown using the MesenCult-XF
®
 system (Fig. 1B). 
 
Phenotype of putative rL-MSC 
Stromal cells cultured from the rabbit corneal limbus (Fig. 2A) displayed a mesenchymal 
morphology similar to that observed in primary cultures of hL-MSC (Fig. 2B) and could be 
readily grown to confluency within one week. The resulting first passage cultures were 
subsequently analysed for expression of the major histo-compatibility complex molecules 
MHC-I and MHC-II (Table 2; Fig. 3E and 3F). This analysis revealed that >90% of rabbit 
cells expressed MHC-I on their surface, while only 10% expressed MHC-II. A panel of 
potential markers for MSC phenotype were also included based upon knowledge of markers 
in other species. Owing to a scarcity of antibodies raised against rabbit cell surface antigens, 
the panel was supplemented with antibodies raised against either mouse or human antigens to 
observe any cross-reactivity. The analysis revealed low levels of reactivity with antibodies 
against rabbit CD45 (<20%) and rabbit CD90 (<10%) (Fig. 3C and 3D). Negligible reactivity 
was observed with any of the mouse-targeted antibodies, including those raised against 
CD29, CD44, CD45 or CD90.2. A similar pattern of poor reactivity was observed towards 
antibodies raised against human MSC antigens with the exception of that raised against 
human CD105 which bound to greater than 50% of cultured rabbit stromal cells (Fig. 3A). A 
modest number of reactive cells (40.84% ± 4.95 SD) were also detected by 
immunocytochemistry using antibody raised against human alpha-smooth muscle actin 
positive cells (Table 2). 
 
“Epithelial stem cell niche” properties of rL-MSC 
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Since hL-MSC are considered to contribute to maintenance of the limbal epithelial stem cell 
niche, we compared the ability of hL-MSC with that of their putative rabbit equivalents to 
support the growth of LE cells using a colony formation assay. Early passage cultures of 
either rabbit or human LE cells retrieved from liquid nitrogen, developed discrete epithelial 
colonies when seeded into dishes containing growth-arrested L-MSC derived from either 
species. The number of colonies formed in each case was two-three fold greater than that 
observed in the absence of L-MSC (Fig. 4).  
 
Immunosuppressive properties of hL-MSC and putative rL-MSC 
L-MSC significantly suppressed T cell proliferation in a mis-matched human MLR 
(p<0.0001; one-way ANOVA). Human L-MSC cultivated in MesenCult-XF
®
 significantly 
reduced human PBMC proliferation in MLR experiments by between 30-60% (p<0.0001) 
when compared with co-cultured PBMC in the absence of L-MSC (Fig. 5A). Human L-MSC 
grown in 10% FBS medium demonstrated lower levels of PBMC immunosuppression 
compared with MesenCult-XF
®
, nonetheless it was also significant (p<0.05). In a xenogeneic 
co-culture, rL-MSC likewise displayed a significant immunosuppressive effect on human 
PBMC allogeneic proliferation, reducing the up-take of tritiated thymidine by approximately 
75% (p<0.0001; Fig. 5B)  
 
Discussion 
While the role of the corneal limbus is well understood with respect to maintaining the 
corneal epithelium (21), the contribution of limbal stromal cells to tissue maintenance and 
repair is by comparison a relatively new field of research (9). The concept of L-MSC with 
similar progenitor cell properties to BM-MSC has thus far proved to be a useful working 
model (7, 11). Nevertheless, the biology and clinical potential of L-MSC remains less clear 
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than their epithelial counterparts residing within the limbal epithelium. Our present findings 
advance the field of L-MSC research in three critical ways. Firstly, we have confirmed that 
human L-MSC maintain a low level of HLA-DR expression irrespective of whether they are 
grown in standard serum-supplemented medium or the MesenCult-XF
®
 system. Nevertheless, 
we reveal dramatic differences in CD146 expression by L-MSC depending upon what culture 
conditions are used. Secondly, we have found that cultures established from the limbal 
stroma of NZW rabbits display similar “epithelial stem cell niche” properties to their human 
counterparts in vitro. The expression of immunological markers by these cells (MHC-I high, 
MHC-II low) is also analogous to human L-MSC (HLA-ABC high, HLA-DR low), but 
suitable markers for rabbit MSC remain elusive. Finally, we present data that confirms the 
immunosuppressive features of both hL-MSC and rL-MSC using the human allogeneic MLR, 
and supports the use of L-MSC in engineered stromal tissue substitutes and stem cell 
therapies to be further examined in a pre-clinical animal model. 
The International Stem Cell Society has defined human MSC as being CD34-, CD45-, 
CD73+, CD90+, CD105+ (22). Previous reports have demonstrated positive expression of the 
same cell surface antigens on human L-MSC (6, 7, 11, 13). Futhermore, recent literature 
suggests low immunogenic properties of hL-MSC by way of positive expression of HLA-
ABC and negative expression of HLA-DR (7, 10). Here we confirm these results, and 
moreover report that hL-MSC cultivated in the MesenCult-XF
®
 culture system also have a 
high percentage of HLA-ABC positive cells and a low percentage of HLA-DR positive cells, 
indicating that the serum-free cultivation of these cells did not disrupt their 
immunosuppressive properties. Another remarkable finding from this study, was the high 
expression of CD146 in hL-MSC grown in serum-supplemented medium, and the lack of its 
expression in cultures grown in MesenCult-XF
®
. CD146 is a cell adhesion molecule that 
belongs to the immunoglobulin superfamily (23). CD146 is considered to be a relatively new 
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MSC marker, and is relevant due to the perivascular origin of the MSC niche (24). Up-
regulation of CD146 has been shown to increase differentiation potential (25, 26). CD146 has 
also been demonstrated to appear on a small subset of T and B lymphocytes, and has been 
thought to play a role in regulating the inflammatory response (27, 28). Nonetheless, in our 
study, the hL-MSC grown in MesenCult-XF
®
 with low CD146 expression, proved to have 
significantly greater immunosuppressive properties to hL-MSC grown in medium containing 
10% FBS. The marked difference observed in CD141 expression between culture conditions 
is consistent with our published data (6), and is most likely due to varying levels of cultured 
endothelial cells, but further studies are required to confirm this. 
Attempts have been made to characterise MSC derived from rabbit bone marrow and 
adipose tissue (29, 30). Tan and colleagues (30) tested a variety of anti-rabbit monoclonal 
antibodies, and anti-human monoclonal antibodies with manufacturer-proven rabbit 
reactivity, via flow cytometry on rBM-MSC. Specifically, they were able to source rabbit 
reactive antibodies for CD29, CD34, CD44, CD45, CD73, CD81, CD90, CD117, and HLA-
DR (30). Their results showed that the rBM-MSC positively expressed anti-rabbit CD29, 
CD44, CD73, CD81, CD90, CD117, with low expression of CD34 (7.1%), CD45 (18%), and 
HLA-DR (4.3%) (30). Other literature has characterised adipose-derived MSC from rabbit 
tissue (29). Although the reactivity of the antibodies used was not specified, the authors 
found that rabbit adipose-derived MSC expressed reactivity for CD13, CD44, CD49f, C59, 
CD90, CD117, and CD166, with low expression of CD105 (20.5%) and HLA-DR (21.5%) 
(29). The present work aimed to characterise MSC-like cells derived from the rabbit limbal 
stroma. It has been demonstrated that hL-MSC possess a similar phenotype and cellular 
properties to that of hBM-MSC (6, 10, 11). Likewise, it would be expected that rL-MSC 
display a similar phenotype to that of rBM-MSC. Our present results show that rL-MSC 
display a similar morphology as that of hL-MSC via light microscopy. Additionally, our 
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results with rL-MSC concur with the previous mentioned studies of rMSC, in that similar 
expression of anti-rabbit CD45 (18.9%) was found, and low expression of HLA-DR (7.29%). 
However our present results demonstrated low expression of anti-rabbit CD90 (7.05%) 
compared with the rBM-MSC (96.9%) (30). Not reported as a marker of MSC (22), CD45 
expression on rabbit-derived BM-MSC and L-MSC in these cases may be due to 
contaminating leukocytes collected during the cell isolation procedure. Further optimisation 
of the MSC isolation process is necessary to obtain a more pure rabbit MSC population. 
Further characterisation of the rabbit-derived L-MSC was hindered by difficulties in sourcing 
anti-rabbit monoclonal antibodies. 
Due to the lack of availability of rabbit antibodies, we investigated the use of anti-
human or anti-mouse antibodies on rL-MSC. We found in the majority of cases that the 
antibodies directed at mice or humans were not compatible with rL-MSC, except in the case 
of anti-human CD45 and CD105. The proportion of rL-MSC in either culture condition that 
displayed positive reactivity with anti-human CD105 was more than that reported in adipose-
derived MSC (29). CD105 expression was not reported in the rBM-MSC study, most likely 
because the authors were unable to source an anti-rabbit equivalent antibody. 
The use of MSC as a stem cell therapy in ocular disorders is a relatively recent 
development; adipose tissue-derived stem cells have been shown to repair and repopulate 
diseased corneas in a rabbit model (31). This study found that human stem cells did not elicit 
an immune response in the rabbit model, and furthermore, the stem cells were able to 
differentiate into functional keratocytes in order to re-build the stem cell niche in the corneal 
stroma (31). Moreover, autologous adipose-derived stem cells applied topically appeared to 
promote corneal epithelial healing (32). BM-MSC have also been reported to differentiate 
into corneal epithelial-like cells to repopulate a damaged epithelial surface (33-35). Although 
the use of human MSC in the treatment of ocular surface disorders appears promising, the 
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ability of hL-MSC to be used in this way has been less studied. Nonetheless, it stands to 
reason that MSC derived from the corneal limbus might be better suited for corneal repair 
and recreating the limbal epithelial stem cell niche. This role for L-MSC has been discussed 
in the recent literature, as they serve to control a niche environment in which LE progenitor 
cells will be generated to repair and maintain the limbal epithelial surface (8, 12, 36). In this 
study, we have shown that L-MSC derived from either rabbit or human tissue support the 
growth of cross-species LE colonies. The ability of MSC to support the growth of epithelial 
colonies is a vital property of stem cells. The colony forming characteristics of hL-MSC has 
been demonstrated previously (7, 11), however the xenogeneic colony forming abilities of 
rL-MSC to support hLE colonies and vice versa is a new concept.  
Garfias and colleagues have recently demonstrated that factors secreted from hL-
MSC are able to suppress proliferation of CD3/CD28+ PBMCs (7). It has also been 
demonstrated that limbal stem cells derived from mice display immunoregulatory properties 
and inhibit pro-inflammatory immune reactions (37). We have demonstrated in the current 
study that rL-MSC and hL-MSC have the ability to suppress allogeneic T cell proliferation in 
a human mismatched MLR. Human L-MSC grown in MesenCult-XF
®
 displayed higher 
levels of immunosuppression than those grown in 10% FBS. These data warrant further 
characterisation of L-MSC and supports the development of a pre-clinical animal model to 
investigate the use of L-MSC as a stem cell therapy. 
 
Conclusion 
This study demonstrates that similar techniques used to isolate hL-MSC may be used to 
isolate rL-MSC. We identified that rL-MSC also contain similar properties to those of hL-
MSC, they were adherent to tissue culture plastic and demonstrated a similar fibroblastic 
spindle shape. Furthermore, the immunosuppressive and immunogenic properties of rL-MSC 
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were found to mimic that displayed by hL-MSC. Our study suggests that rL-MSC may be 
useful for the development of an animal model to investigate stem cell therapies for ocular 
surface disorders. A lack of minimal criteria for the characterisation of rL-MSC also means 
that this work will provide a valuable foundation for future profiling of these cells. 
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23 
Tables 
 
Table 1. Effect of culture conditions on the expression of human leukocyte antigens (HLA) by human limbal mesenchymal stromal cells (hL-
MSC). First passage cultures of human L-MSC were examined by flow cytometry for cell surface expression of HLA-ABC and HLA-DR. A 
panel of markers for human MSC phenotype is included for comparison. The cultures were established in either serum-supplemented growth 
medium (hL-MSC FBS) or using the MesenCult-XF
®
 system (hL-MSC MesenCult). Data shows mean ± SD (n = 9). 
 
Culture 
condition 
HLA-
ABC 
HLA-
DR 
CD29 CD34 CD44 CD45 CD73 CD90 CD105 CD141 CD146 
hL-MSC FBS 81.42 ± 
2.86 
32.88 ± 
5.34 
84.13 ± 
8.12 
0.61 ± 
0.87 
87.86 ± 
5.15 
2.60 ± 
0.89 
93.07 ± 
2.27 
97.98 ± 
1.21 
92.24 ± 
1.44 
3.15 ± 
2.90 
81.17 ± 
4.12 
hL-MSC 
MesenCult 
81.94 ± 
4.86 
16.90 ± 
5.68 
96.22 ± 
0.98 
0.05 ± 
0.08 
97.03 ± 
1.24 
1.91 ± 
1.02 
98.08 ± 
0.24 
98.97 ± 
0.63 
95.91 ± 
0.84 
39.03 ± 
0.98 
1.10 ± 
1.06 
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Table 2. Analysis of major histocompatibility complex (MHC) molecules expressed on the surface of putative rabbit limbal mesenchymal 
stromal cells (rL-MSC). First passage cultures of rL-MSC grown in serum-supplemented growth medium were analysed by flow cytometry for 
MHC-I and MHC-II. A panel of potential markers of MSC phenotype is also included. Owing to a scarcity of antibodies available for rabbit 
antigens, a number of key anti-human and anti-mouse antibodies have been tested for potential cross-reactivity. Data shows mean ± SD (n = 9). 
 
Species of 
antigen 
MHC-I MHC-II CD29 CD34 CD44 CD45 CD73 CD90 
CD90.2 
CD105 CD141 CD146 α-sma 
Rabbit 94.40 ± 
2.60 
10.50 ± 
5.26 
- - - 18.90 ± 
5.96 
- 7.05 ± 
1.29 
- - -  
Mouse - - 0.92 ± 
0.21 
- 1.10 ± 
0.12 
1.46 ± 
0.41 
- 0.88 ± 
0.07 
- - -  
Human 
 
- - - 0.00 ± 
0.00 
- 0.51 ± 
0.14 
0.10 ± 
0.05 
4.33 ± 
0.24 
57.38 ± 
7.80 
0.07 ± 
0.06 
0.95 ± 
0.14 
40.84 ± 
4.95 
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Figures 
 
 
Figure 1. Comparison of CD146 expression on human L-MSC (hL-MSC) established in 
either (A) serum-supplemented growth medium (10% FBS) or, (B) using the MesenCult-XF
®
 
system.  
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Figure 2. Comparison of L-MSC cultures derived from either rabbit (A) or human tissue (B) 
grown in serum-supplemented medium as viewed by phase contrast microscopy. Scale bar = 
100µm. 
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Figure 3. Key examples of flow cytometry results for rabbit L-MSC (rL-MSC) cultures using 
antibodies raised against either human (A and B) or rabbit (C to F) cell surface antigens. 
Refer to Table 1 for complete summary of all antibodies tested. 
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Figure 4. Comparison of colony formation by limbal epithelial (LE) cells (human or rabbit) in 
the presence of either human (hL-MSC) or rabbit limbal MSC (rL-MSC). Results of two-way 
ANOVA when compared to respective growth in absence of either LMSC cell type: *p<0.05, 
**p<0.001). 
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Figure 5. Suppression of leukocyte proliferation by either (A) human L-MSC, or (B) rabbit 
L-MSC. Peripheral blood mono-nuclear cells (PBMC) from two mis-matched human donors 
were cultured together for 4 days and the resulting co-activation of leukocyte proliferation 
measured by uptake of tritiated thymidine. The resulting bars display label uptake in the 
absence of L-MSC (Control), or presence of growth-arrested L-MSC. In part A, “FBS” and 
“MesenCult” refer to the different culture conditions initially used to establish and expand the 
human L-MSC cultures. For both parts A and B, bars represent the mean  SEM for values 
obtained from six experiments (n=6). Asterisks indicates significant difference to control (* 
p<0.05; ** p<0.0001). Each experiment was performed in quadruplicate. 
